PHATUS
Phathom Pharmaceuticals Inc.
On the 100× in 15 years screenOn the 10× in 5 years screenAsset-lightPre-profit
Market cap
$868M
Revenue CAGR
+1502%
Rev/share CAGR
+1244%
Archetype
Asset-light
Why it's on the screen
Phathom Pharmaceuticals Inc. cleared Multibagger's gates and scoring as a business with multibagger characteristics.
Read the full thesis
The complete write-up, every metric, and all 1,000+ names on the screen are for members. Free members see the top 3 of each screen; Pro unlocks everything.
More on the screen
Research information only. Not investment advice or a recommendation. Valuation is excluded from this screen; figures reflect the latest snapshot and may differ from live market data. Securities are selected by a rules-based screen. Any positions held by Multibagger or its principals have no bearing on that process or on which securities are covered. Disclosures.